<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33780087</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-3639</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Brain pathology (Zurich, Switzerland)</Title><ISOAbbreviation>Brain Pathol</ISOAbbreviation></Journal><ArticleTitle>Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.</ArticleTitle><Pagination><StartPage>e12948</StartPage><MedlinePgn>e12948</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e12948</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/bpa.12948</ELocationID><Abstract><AbstractText>Accumulating evidence suggests X-linked dominant mutations in UBQLN2 cause amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) through both loss- and gain-of-function mechanisms. However, the mechanisms by which the mutations cause disease are still unclear. The goal of the study was to uncover the possible pathomechanism(s) by which UBQLN2 mutations cause ALS/FTD. An analysis of proteomic changes in neuronal tissue was used to identify proteins with altered accumulation in the P497S UBQLN2 transgenic mouse model of ALS/FTD. We then used immunocytochemistry and biochemical techniques to confirm protein changes in the mutant P497S mice. Additionally, we used cell lines inactivated of UBQLN2 expression to determine whether its loss underlies the alteration in the proteins seen in P497S mice. The proteome screen identified a dramatic alteration of serine protease inhibitor (serpin) proteins in the mutant P497S animals. Double immunofluorescent staining of brain and spinal cord tissues of the mutant and control mice revealed an age-dependent change in accumulation of Serpin A1, C1, and I1 in puncta whose staining colocalized with UBQLN2 puncta in the mutant P497S mice. Serpin A1 aggregation in P497S animals was confirmed by biochemical extraction and filter retardation assays. A similar phenomenon of serpin protein aggregation was found in HeLa and NSC34 motor neuron cells with inactivated UBQLN2 expression. We found aberrant aggregation of serpin proteins, particularly Serpin A1, in the brain and spinal cord of the P497S UBQLN2 mouse model of ALS/FTD. Similar aggregation of serpin proteins was found in UBQLN2 knockout cells suggesting that serpin aggregation in the mutant P497S animals may stem from loss of UBQLN2 function. Because serpin aggregation is known to cause disease through both loss- and gain-of-function mechanisms, we speculate that their accumulation in the P497S mouse model of ALS/FTD may contribute to disease pathogenesis through similar mechanism(s).</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Brain Pathology published by John Wiley &amp; Sons Ltd on behalf of International Society of Neuropathology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Nicole R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenslade</LastName><ForeName>Jessie E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Josephine J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnologies 'Charles Darwin', Pasteur Institute - Cenci Bolognetti Foundation, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galliciotti</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Mervyn J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-1740-5309</Identifier><AffiliationInfo><Affiliation>Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS098243</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS100008</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS098243</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Pathol</MedlineTA><NlmUniqueID>9216781</NlmUniqueID><ISSNLinking>1015-6305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015843">Serpins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C538988">UBQLN2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015843" MajorTopicYN="N">Serpins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ubiquilin-2 (UBQLN2)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia (FTD)</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">serpin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>29</Day><Hour>13</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33780087</ArticleId><ArticleId IdType="mid">NIHMS1697093</ArticleId><ArticleId IdType="pmc">PMC8387369</ArticleId><ArticleId IdType="doi">10.1111/bpa.12948</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al&#x2010;Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al&#x2010;Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386:1672&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X&#x2010;linked juvenile and adult&#x2010;onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins N, Lin B, Monteiro MJ. Lou Gehrig's disease (ALS): UBQLN2 mutations strike out of phase. Structure. 2019;27:879&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267892</ArticleId><ArticleId IdType="pubmed">31167121</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L, Picher&#x2010;Martel V, Codron P, Julien JP. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun. 2019;7:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng T, Yang Y, Castaneda CA. Structure, dynamics and functions of UBQLNs: at the crossroads of protein quality control machinery. Biochem J. 2020;477:3471&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737201</ArticleId><ArticleId IdType="pubmed">32965492</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Monteiro MJ. Defective proteasome delivery of polyubiquitinated proteins by Ubiquilin&#x2010;2 proteins containing ALS mutations. PLoS One. 2015;10:e0130162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JJ, Cai A, Greenslade JE, Higgins NR, Fan C, Le NTT, et al. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc Natl Acad Sci U S A. 2020;117:15230&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Yan LH, Huang B, Liu M, Liu X, Huang C. Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum&#x2010;associated protein degradation. J Neurochem. 2014;129:99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24215460</ArticleId></ArticleIdList></Reference><Reference><Citation>Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, et al. Motor neuron disease, TDP&#x2010;43 pathology, and memory deficits in mice expressing ALS&#x2010;FTD&#x2010;linked UBQLN2 mutations. Proc Natl Acad Sci U S A. 2016;113:E7580&#x2013;E7589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit C, Jackson BC, McAndrews M, Wright MW, Thompson DC, Silverman GA, et al. Update of the human and mouse SERPIN gene superfamily. Hum Genomics. 2013;7:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880077</ArticleId><ArticleId IdType="pubmed">24172014</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington JA. Serpin structure, function and dysfunction. J Thromb Haemost. 2011;9(Suppl 1):26&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21781239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102:4751&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">12475206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gettins PG, Olson ST. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance. Biochem J. 2016;473:2273&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5266585</ArticleId><ArticleId IdType="pubmed">27470592</ArticleId></ArticleIdList></Reference><Reference><Citation>Law RH, Zhang Q, McGowan S, Buckle AM, Silverman GA, Wong W, et al. An overview of the serpin superfamily. Genome Biol. 2006;7:216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1779521</ArticleId><ArticleId IdType="pubmed">16737556</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright HT, Scarsdale JN. Structural basis for serpin inhibitor activity. Proteins. 1995;22:210&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">7479695</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies MJ, Lomas DA. The molecular aetiology of the serpinopathies. Int J Biochem Cell Biol. 2008;40(6&#x2013;7):1273&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18289918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nat Rev Genet. 2002;3:759&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">12360234</ArticleId></ArticleIdList></Reference><Reference><Citation>Le A, Ferrell GA, Dishon DS, Le QQ, Sifers RN. Soluble aggregates of the human PiZ alpha 1&#x2010;antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. J Biol Chem. 1992;267:1072&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">1530934</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda E, Romisch K, Lomas DA. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem. 2004;279:28283&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Z, Wang H, Fan H, Wang G. The endoplasmic reticulum (ER)&#x2010;associated degradation system regulates aggregation and degradation of mutant neuroserpin. J Biol Chem. 2011;286:20835&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3121498</ArticleId><ArticleId IdType="pubmed">21507957</ArticleId></ArticleIdList></Reference><Reference><Citation>Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha&#x2010;1&#x2010;antitrypsin deficiency. Am J Med. 1988;84(6A):13&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">3289385</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, et al. Familial dementia caused by polymerization of mutant neuroserpin. Nature. 1999;401:376&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10517635</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa&#x2010;Mattioli M, Walter P. The integrated stress response: From mechanism to disease. Science. 2020;368(6489):eaat5314.</Citation><ArticleIdList><ArticleId IdType="pubmed">32327570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano R. Reed JC (2013) ER stress&#x2010;induced cell death mechanisms. Biochim Biophys Acta. 1833;12:3460&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834229</ArticleId><ArticleId IdType="pubmed">23850759</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011;13:184&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107571</ArticleId><ArticleId IdType="pubmed">21364565</ArticleId></ArticleIdList></Reference><Reference><Citation>Belorgey D, Hagglof P, Karlsson&#x2010;Li S, Lomas DA. Protein misfolding and the serpinopathies. Prion. 2007;1:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2633702</ArticleId><ArticleId IdType="pubmed">19164889</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, et al. Structure and variation of human alpha 1&#x2010;antitrypsin. Nature. 1982;298:329&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">7045697</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington JA. Shape&#x2010;shifting serpins&#x2013;advantages of a mobile mechanism. Trends Biochem Sci. 2006;31:427&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiserman D, Whisstock JC, Bird PI. Mechanisms of serpin dysfunction in disease. Expert Rev Mol Med. 2006;8:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17156576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Tatman M, Monteiro MJ. Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD. Acta Neuropathol Commun. 2020;8:164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539388</ArticleId><ArticleId IdType="pubmed">33028421</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro MJ, Mical TI. Resolution of kinase activities during the HeLa cell cycle: identification of kinases with cyclic activities. Exp Cell Res. 1996;223:443&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8601422</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Monteiro MJ. Identification and characterization of a novel (115 kDa) neurofilament&#x2010;associated kinase. J Neurosci. 1994;14(3 Pt 2):1820&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577529</ArticleId><ArticleId IdType="pubmed">8126574</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin&#x2010;positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol. 2006;169:1343&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1780184</ArticleId><ArticleId IdType="pubmed">17003490</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley AM, Prado MA, de Poot SAH, Paulo JA, Ashton M, Dominguez S, et al. Global proteomics of Ubqln2&#x2010;based murine models of ALS. J Biol Chem. 2020. 10.1074/jbc.RA120.015960</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015960</ArticleId><ArticleId IdType="pmc">PMC7873701</ArticleId><ArticleId IdType="pubmed">33277362</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha 1&#x2010;antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 1988;52:487&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">3257719</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu&#x2010;Rumeileh S, Halbgebauer S, Steinacker P, Anderl&#x2010;Straub S, Polischi B, Ludolph AC, et al. CSF SerpinA1 in Creutzfeldt&#x2010;Jakob disease and frontotemporal lobar degeneration. Ann Clin Transl Neurol. 2020;7:191&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034504</ArticleId><ArticleId IdType="pubmed">31957347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert MTW, Ross CA, Pregent LJ, Lank RJ, Zhang C, Katzman RB, et al. Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72&#x2010;associated and sporadic ALS, and implicates SERPINA1 in disease. Acta Neuropathol. 2017;134:715&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5647251</ArticleId><ArticleId IdType="pubmed">28808785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen HM, Minthon L, Londos E, Blennow K, Miranda E, Perez J, et al. Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies. Neurology. 2007;69:1569&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">17761554</ArticleId></ArticleIdList></Reference><Reference><Citation>von Neuhoff N, Oumeraci T, Wolf T, Kollewe K, Bewerunge P, Neumann B, et al. Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic. PLoS One. 2012;7:e44401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3435306</ArticleId><ArticleId IdType="pubmed">22970211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wormser U, Mandrioli J, Vinceti M, Fini N, Sintov A, Brodsky B, et al. Reduced levels of alpha&#x2010;1&#x2010;antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment. J Neuroinflammation. 2016;13:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888657</ArticleId><ArticleId IdType="pubmed">27245439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, et al. Human and mouse single&#x2010;nucleus transcriptomics reveal TREM2&#x2010;dependent and TREM2&#x2010;independent cellular responses in Alzheimer's disease. Nat Med. 2020;26:131&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci. 2017;18:e1865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426:895&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14685250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooptu B, Lomas DA. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem. 2009;78:147&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">19245336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas DA, Elliott PR, Sidhar SK, Foreman RC, Finch JT, Cox DW, et al. alpha 1&#x2010;Antitrypsin Mmalton (Phe52&#x2010;deleted) forms loop&#x2010;sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem. 1995;270:16864&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">7622502</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature. 2000;404:770&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10783891</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, et al. Huntingtin&#x2010;encoded polyglutamine expansions form amyloid&#x2010;like protein aggregates in vitro and in vivo. Cell. 1997;90:549&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">9267034</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu MH, Lee KN, Kim J. The Z type variation of human alpha 1&#x2010;antitrypsin causes a protein folding defect. Nat Struct Biol. 1995;2:363&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7664092</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu D, Teckman JH, Omura S, Perlmutter DH. Degradation of a mutant secretory protein, alpha1&#x2010;antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem. 1996;271:22791&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8798455</ArticleId></ArticleIdList></Reference><Reference><Citation>Badola S, Spurling H, Robison K, Fedyk ER, Silverman GA, Strayle J, et al. Correlation of serpin&#x2010;protease expression by comparative analysis of real&#x2010;time PCR profiling data. Genomics. 2006;88:173&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Brodsky JL. Protein quality control in the secretory pathway. J Cell Biol. 2019;218:3171&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6781448</ArticleId><ArticleId IdType="pubmed">31537714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature. 2016;529:326&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26791723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekhar K, Ke H, Wang N, Goodwin T, Gierasch LM, Gershenson A, et al. Cellular folding pathway of a metastable serpin. Proc Natl Acad Sci U S A. 2016;113:6484&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4988602</ArticleId><ArticleId IdType="pubmed">27222580</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies MJ, Miranda E, Roussel BD, Kaufman RJ, Marciniak SJ, Lomas DA. Neuroserpin polymers activate NF&#x2010;kappaB by a calcium signaling pathway that is independent of the unfolded protein response. J Biol Chem. 2009;284:18202&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709363</ArticleId><ArticleId IdType="pubmed">19423713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroeger H, Miranda E, MacLeod I, Perez J, Crowther DC, Marciniak SJ, et al. Endoplasmic reticulum&#x2010;associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J Biol Chem. 2009;284:22793&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2755687</ArticleId><ArticleId IdType="pubmed">19549782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomas DA, Hurst JR, Gooptu B. Update on alpha&#x2010;1 antitrypsin deficiency: New therapies. J Hepatol. 2016;65:413&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27034252</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipanski A, Oberhauser F, Neumann M, Lange S, Szalay B, Krasemann S, et al. Lectin OS&#x2010;9 delivers mutant neuroserpin to endoplasmic reticulum associated degradation in familial encephalopathy with neuroserpin inclusion bodies. Neurobiol Aging. 2014;35:2394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24795221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim PJ, Danner R, Liang J, Doong H, Harman C, Srinivasan D, et al. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J Cell Biol. 2009;187:201&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768832</ArticleId><ArticleId IdType="pubmed">19822669</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran M, Ragagnin AMG, Vidal M, Parakh S, Yang S, Heng B, et al. Amyotrophic lateral sclerosis&#x2010;linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress. Cell Mol Life Sci. 2020;77(19):3859&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">31802140</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JA, Yerbury JJ, Farrawell N, Shearer RF, Constantinescu P, Hatters DM, et al. SerpinB2 (PAI&#x2010;2) modulates proteostasis via binding misfolded proteins and promotion of cytoprotective inclusion formation. PLoS One. 2015;10:e0130136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470917</ArticleId><ArticleId IdType="pubmed">26083412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelling CL, Brodsky JL. Mechanisms underlying the cellular clearance of antitrypsin Z: lessons from yeast expression systems. Proc Am Thorac Soc. 2010;7:363&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136956</ArticleId><ArticleId IdType="pubmed">21030514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamimoto T, Shoji S, Hidvegi T, Mizushima N, Umebayashi K, Perlmutter DH, et al. Intracellular inclusions containing mutant alpha1&#x2010;antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem. 2006;281:4467&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">16365039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounnas MZ, Church FC, Argraves WS, Strickland DK. Cellular internalization and degradation of antithrombin III&#x2010;thrombin, heparin cofactor II&#x2010;thrombin, and alpha 1&#x2010;antitrypsin&#x2010;trypsin complexes is mediated by the low density lipoprotein receptor&#x2010;related protein. J Biol Chem. 1996;271:6523&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8626456</ArticleId></ArticleIdList></Reference><Reference><Citation>Fra A, Cosmi F, Ordonez A, Berardelli R, Perez J, Guadagno NA, et al. Polymers of Z alpha1&#x2010;antitrypsin are secreted in cell models of disease. Eur Respir J. 2016;47:1005&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26846838</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington JA, Sendall TJ, Yamasaki M. New insight into serpin polymerization and aggregation. Prion. 2009;3:12&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676738</ArticleId><ArticleId IdType="pubmed">19372754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SM, Taniguchi A, Wang HS, Festoff BW. Serpin=serine protease&#x2010;like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis. J Neurol Sci. 1998;160(Suppl 1):S73&#x2013;S79.</Citation><ArticleIdList><ArticleId IdType="pubmed">9851654</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Simpson EP, Appel SH. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol. 2018;31:635&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Arecco N, Clarke CJ, Jones FK, Simpson DM, Mason D, Beynon RJ, et al. Elastase levels and activity are increased in dystrophic muscle and impair myoblast cell survival, proliferation and differentiation. Sci Rep. 2016;6:24708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886533</ArticleId><ArticleId IdType="pubmed">27241590</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018;3:e123249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong D, Farley K, White M, Hartshorn KL, Benarafa C, Remold&#x2010;O'Donnell E. Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection. J Infect Dis. 2011;204:592&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144176</ArticleId><ArticleId IdType="pubmed">21791661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasumatsu R, Altiok O, Benarafa C, Yasumatsu C, Bingol&#x2010;Karakoc G, Remold&#x2010;O'Donnell E, et al. SERPINB1 upregulation is associated with in vivo complex formation with neutrophil elastase and cathepsin G in a baboon model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2006;291:L619&#x2013;L627.</Citation><ArticleIdList><ArticleId IdType="pubmed">16617093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould TW, Dominguez B, de Winter F, Yeo GW, Liu P, Sundararaman B, et al. Glial cells maintain synapses by inhibiting an activity&#x2010;dependent retrograde protease signal. PLoS Genet. 2019;15:e1007948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417855</ArticleId><ArticleId IdType="pubmed">30870413</ArticleId></ArticleIdList></Reference><Reference><Citation>Amara U, Rittirsch D, Flierl M, Bruckner U, Klos A, Gebhard F, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008;632:71&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713875</ArticleId><ArticleId IdType="pubmed">19025115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HA, Lee JD, Lee KM, Woodruff TM, Noakes PG. Complement C5a&#x2013;C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. Skelet Muscle. 2017;7:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5455206</ArticleId><ArticleId IdType="pubmed">28571586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran R, Noorbakhsh F, Defea K, Hollenberg MD. Targeting proteinase&#x2010;activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov. 2012;11:69&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">22212680</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakker&#x2010;Varia S, Elkabes S, Schick C, Silverman GA, Peng L, Sherwood AC, et al. Gene expression in activated brain microglia: identification of a proteinase inhibitor that increases microglial cell number. Brain Res Mol Brain Res. 1998;56(1&#x2013;2):99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">9602079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Velmeshev D, Hashimoto K, Huang YH, Hofmann JW, Shi X, et al. Neurotoxic microglia promote TDP&#x2010;43 proteinopathy in progranulin deficiency. Nature. 2020;588:459&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>